Prostate cancer diagnostic solutions: Deliver diagnostic confidence

Recent translational research is showing that much like soft tissue cancers, prostate cancer can now be subtyped according to molecular signature with immunohistochemistry techniques, which may enable the identification of aggressive versus indolent disease. We are committed to the development of innovative tools to better identify and subtype prostate cancer—so you can deliver the right test, with clinical confidence, in the shortest possible time.